|
EP1771470B1
(en)
|
2004-07-23 |
2013-06-26 |
Acceleron Pharma Inc. |
Actrii receptor polypeptides, methods and compositions
|
|
US8067562B2
(en)
|
2005-11-01 |
2011-11-29 |
Amgen Inc. |
Isolated nucleic acid molecule comprising the amino acid sequence of SEQ ID NO:1
|
|
US8128933B2
(en)
|
2005-11-23 |
2012-03-06 |
Acceleron Pharma, Inc. |
Method of promoting bone growth by an anti-activin B antibody
|
|
KR20190006086A
(ko)
|
2005-11-23 |
2019-01-16 |
악셀레론 파마 인코포레이티드 |
액티빈-ａｃｔｒⅱａ 길항제 및 골 성장을 촉진하기 위한 이들의 용도
|
|
CL2007002567A1
(es)
*
|
2006-09-08 |
2008-02-01 |
Amgen Inc |
Proteinas aisladas de enlace a activina a humana.
|
|
DK2124999T3
(da)
|
2006-12-18 |
2013-01-14 |
Acceleron Pharma Inc |
Activin-actrii antagonister og anvendelser til behandling af anæmi
|
|
US8895016B2
(en)
|
2006-12-18 |
2014-11-25 |
Acceleron Pharma, Inc. |
Antagonists of activin-actriia and uses for increasing red blood cell levels
|
|
EP2111229B1
(en)
|
2007-02-01 |
2013-04-10 |
Acceleron Pharma, Inc. |
Pharmaceutical compositions comprising Activin-ActRIIA antagonists for use in preventing or treating breast cancer metastasis or breast cancer related bone loss
|
|
TWI782836B
(zh)
|
2007-02-02 |
2022-11-01 |
美商艾瑟勒朗法瑪公司 |
衍生自ActRIIB的變體與其用途
|
|
ES2756725T3
(es)
|
2007-02-09 |
2020-04-27 |
Acceleron Pharma Inc |
Composiciones farmacéuticas que comprenden antagonistas de Activina-ActRIIA
|
|
US8501678B2
(en)
|
2007-03-06 |
2013-08-06 |
Atara Biotherapeutics, Inc. |
Variant activin receptor polypeptides and uses thereof
|
|
TWI573802B
(zh)
|
2007-03-06 |
2017-03-11 |
安美基公司 |
變異之活動素受體多肽及其用途
|
|
CA2698103A1
(en)
*
|
2007-08-31 |
2009-03-05 |
Amgen Inc. |
Solid-state protein formulation
|
|
EP3243524A1
(en)
|
2007-09-18 |
2017-11-15 |
Acceleron Pharma Inc. |
Activin-actriia antagonists and uses for decreasing or inhibiting fsh secretion
|
|
US8216997B2
(en)
|
2008-08-14 |
2012-07-10 |
Acceleron Pharma, Inc. |
Methods for increasing red blood cell levels and treating anemia using a combination of GDF traps and erythropoietin receptor activators
|
|
SMT202300222T1
(it)
|
2008-08-14 |
2023-09-06 |
Acceleron Pharma Inc |
Trappole di gdf
|
|
SG10201703067QA
(en)
|
2008-11-26 |
2017-05-30 |
Amgen Inc |
Variants Of Activin IIB Receptor Polypeptides And Uses Thereof
|
|
US8138142B2
(en)
|
2009-01-13 |
2012-03-20 |
Acceleron Pharma Inc. |
Methods for increasing adiponectin in a patient in need thereof
|
|
BRPI1010587A2
(pt)
|
2009-06-08 |
2019-04-09 |
Acceleron Pharma Inc. |
métodos para aumentar adipócitos termogênicos
|
|
EP2440577A4
(en)
|
2009-06-12 |
2013-01-23 |
Acceleron Pharma Inc |
SHORTEN ACTRIIB FC FUSION PROTEINS
|
|
MX344382B
(es)
|
2009-10-23 |
2016-12-14 |
Amgen Inc * |
Adaptador de vial y sistema.
|
|
JP6267425B2
(ja)
|
2009-11-17 |
2018-01-24 |
アクセルロン ファーマ， インコーポレイテッド |
筋ジストロフィー治療のためのユートロフィン誘導に関するａｃｔｒｉｉｂタンパク質およびその改変体およびその使用
|
|
JO3340B1
(ar)
|
2010-05-26 |
2019-03-13 |
Regeneron Pharma |
مضادات حيوية لـعامل تمايز النمو 8 البشري
|
|
WO2011156373A1
(en)
|
2010-06-07 |
2011-12-15 |
Amgen Inc. |
Drug delivery device
|
|
US8999343B2
(en)
|
2010-08-16 |
2015-04-07 |
Amgen Inc. |
Antibodies that bind myostatin, compositions and methods
|
|
CN103298832A
(zh)
*
|
2010-11-08 |
2013-09-11 |
阿塞勒隆制药公司 |
Actriia结合剂及其用途
|
|
CA2831100C
(en)
|
2011-03-31 |
2020-02-18 |
Mark Dominis Holt |
Vial adapter and system
|
|
EP2699293B8
(en)
|
2011-04-20 |
2022-07-20 |
Amgen Inc. |
Autoinjector apparatus
|
|
ES2675035T3
(es)
|
2011-10-14 |
2018-07-05 |
Amgen, Inc |
Inyector y método de ensamblaje
|
|
AU2012339722B2
(en)
*
|
2011-11-14 |
2017-09-14 |
Regeneron Pharmaceuticals, Inc. |
Compositions and methods for increasing muscle mass and muscle strength by specifically antagonizing GDF8 and/or Activin A
|
|
HK1203384A1
(en)
|
2011-12-19 |
2015-12-11 |
Amgen Inc. |
Variant activin receptor polypeptides, alone or in combination with chemotherapy, and uses thereof
|
|
NZ707477A
(en)
|
2012-11-02 |
2019-09-27 |
Celgene Corp |
Activin-actrii antagonists and uses for treating bone and other disorders
|
|
UY35148A
(es)
|
2012-11-21 |
2014-05-30 |
Amgen Inc |
Immunoglobulinas heterodiméricas
|
|
EP3656426B1
(en)
|
2012-11-21 |
2023-05-17 |
Amgen Inc. |
Drug delivery device
|
|
SG10201706148WA
(en)
*
|
2013-02-01 |
2017-08-30 |
Santa Maria Biotherapeutics Inc |
Administration of an anti-activin-a compound to a subject
|
|
CA2904661C
(en)
|
2013-03-15 |
2022-03-15 |
Amgen Inc. |
Drug cassette, autoinjector, and autoinjector system
|
|
WO2014144817A2
(en)
|
2013-03-15 |
2014-09-18 |
Amgen Inc. |
Inhibitory polypeptides specific to wnt inhibitors
|
|
EP2968760B1
(en)
|
2013-03-15 |
2024-01-03 |
Amgen Inc. |
Drug cassette, autoinjector, and autoinjector system
|
|
IL292270B2
(en)
|
2013-03-22 |
2024-04-01 |
Amgen Inc |
Injector and method of assembly
|
|
TW201920262A
(zh)
*
|
2013-07-30 |
2019-06-01 |
美商再生元醫藥公司 |
抗活化素ａ之抗體及其用途
|
|
EP3712166A1
(en)
|
2013-09-05 |
2020-09-23 |
Amgen Inc. |
Fc-containing molecules exhibiting predictable, consistent, and reproducible glycoform profiles
|
|
EP4331605A3
(en)
|
2013-09-13 |
2024-05-22 |
F. Hoffmann-La Roche AG |
Methods and compositions comprising purified recombinant polypeptides
|
|
ES2915378T3
(es)
|
2013-09-13 |
2022-06-22 |
Hoffmann La Roche |
Procedimientos para detectar y cuantificar una proteína de célula huésped en líneas celulares
|
|
ES3062706T3
(en)
|
2013-10-24 |
2026-04-13 |
Amgen Inc |
Drug delivery system with temperature-sensitive control
|
|
MX373358B
(es)
|
2013-10-24 |
2020-07-06 |
Amgen Inc |
Inyector y método de montaje.
|
|
WO2015119906A1
(en)
|
2014-02-05 |
2015-08-13 |
Amgen Inc. |
Drug delivery system with electromagnetic field generator
|
|
KR102496507B1
(ko)
|
2014-05-07 |
2023-02-03 |
암겐 인코포레이티드 |
충격 감소 요소들을 가진 자동 주사기
|
|
US10156562B2
(en)
|
2014-05-16 |
2018-12-18 |
Amgen Inc. |
Assay for detecting Th1 and Th2 cell populations
|
|
US20170103186A1
(en)
|
2014-06-03 |
2017-04-13 |
Amgen Inc. |
Systems and methods for supporting patient use of a drug delivery device
|
|
WO2015192111A1
(en)
|
2014-06-13 |
2015-12-17 |
Acceleron Pharma, Inc. |
Methods and compositions for treating ulcers
|
|
US20160075772A1
(en)
*
|
2014-09-12 |
2016-03-17 |
Regeneron Pharmaceuticals, Inc. |
Treatment of Fibrodysplasia Ossificans Progressiva
|
|
MA41052A
(fr)
|
2014-10-09 |
2017-08-15 |
Celgene Corp |
Traitement d'une maladie cardiovasculaire à l'aide de pièges de ligands d'actrii
|
|
EP3206739B1
(en)
|
2014-10-14 |
2021-12-01 |
Amgen Inc. |
Drug injection device with visual and audio indicators
|
|
JP2018501307A
(ja)
|
2014-12-03 |
2018-01-18 |
セルジーン コーポレイション |
アクチビン−ＡｃｔＲＩＩアンタゴニスト及び貧血を治療するための使用
|
|
US11357916B2
(en)
|
2014-12-19 |
2022-06-14 |
Amgen Inc. |
Drug delivery device with live button or user interface field
|
|
WO2016100781A1
(en)
|
2014-12-19 |
2016-06-23 |
Amgen Inc. |
Drug delivery device with proximity sensor
|
|
CA2976935C
(en)
|
2015-02-17 |
2020-03-10 |
Amgen Inc. |
Drug delivery device with vacuum assisted securement and/or feedback
|
|
EP3261690B1
(en)
|
2015-02-27 |
2021-12-15 |
Amgen Inc. |
Drug delivery device having a needle guard mechanism with a tunable threshold of resistance to needle guard movement
|
|
EA039118B1
(ru)
*
|
2015-04-01 |
2021-12-07 |
Ридженерон Фармасьютикалз, Инк. |
Способ лечения прогрессирующей оссифицирующей фибродисплазии
|
|
WO2016168613A1
(en)
|
2015-04-15 |
2016-10-20 |
Regeneron Pharmaceuticals, Inc. |
Methods of increasing strength and functionality with gdf8 inhibitors
|
|
JP2018518461A
(ja)
|
2015-04-29 |
2018-07-12 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． |
進行性骨化性線維異形成症の治療
|
|
US10618976B2
(en)
|
2015-06-16 |
2020-04-14 |
The Board Of Trustees Of The Leland Stanford Junior University |
SIRP-α agonist antibody
|
|
PE20180802A1
(es)
|
2015-08-05 |
2018-05-09 |
Janssen Biotech Inc |
Anticuerpos anti-cd154 y metodos de uso de estos
|
|
WO2017039786A1
(en)
|
2015-09-02 |
2017-03-09 |
Amgen Inc. |
Syringe assembly adapter for a syringe
|
|
US11351308B2
(en)
|
2015-12-09 |
2022-06-07 |
Amgen Inc. |
Auto-injector with signaling cap
|
|
US11154661B2
(en)
|
2016-01-06 |
2021-10-26 |
Amgen Inc. |
Auto-injector with signaling electronics
|
|
TWI736575B
(zh)
|
2016-01-22 |
2021-08-21 |
美商默沙東藥廠 |
抗凝固因子ｘｉ抗體
|
|
US11236156B2
(en)
|
2016-02-11 |
2022-02-01 |
The Johns Hopkins University |
Compositions and methods for targeting activin signaling to treat cancer
|
|
ES2814287T3
(es)
|
2016-03-15 |
2021-03-26 |
Amgen Inc |
Reducir la probabilidad de rotura de cristal en dispositivos de administración de fármaco
|
|
US11541168B2
(en)
|
2016-04-29 |
2023-01-03 |
Amgen Inc. |
Drug delivery device with messaging label
|
|
WO2017192287A1
(en)
|
2016-05-02 |
2017-11-09 |
Amgen Inc. |
Syringe adapter and guide for filling an on-body injector
|
|
AU2017263558B2
(en)
|
2016-05-13 |
2022-12-22 |
Amgen Inc. |
Vial sleeve assembly
|
|
US11238150B2
(en)
|
2016-05-16 |
2022-02-01 |
Amgen Inc. |
Data encryption in medical devices with limited computational capability
|
|
US11541176B2
(en)
|
2016-06-03 |
2023-01-03 |
Amgen Inc. |
Impact testing apparatuses and methods for drug delivery devices
|
|
IL263272B2
(en)
|
2016-06-14 |
2025-07-01 |
Merck Sharp & Dohme |
Antibodies to coagulation factor xi
|
|
WO2018004842A1
(en)
|
2016-07-01 |
2018-01-04 |
Amgen Inc. |
Drug delivery device having minimized risk of component fracture upon impact events
|
|
WO2018034784A1
(en)
|
2016-08-17 |
2018-02-22 |
Amgen Inc. |
Drug delivery device with placement detection
|
|
WO2018081234A1
(en)
|
2016-10-25 |
2018-05-03 |
Amgen Inc. |
On-body injector
|
|
US20190358411A1
(en)
|
2017-01-17 |
2019-11-28 |
Amgen Inc. |
Injection devices and related methods of use and assembly
|
|
US11752258B2
(en)
|
2017-02-17 |
2023-09-12 |
Amgen Inc. |
Drug delivery device with sterile fluid flowpath and related method of assembly
|
|
MX2019009755A
(es)
|
2017-02-17 |
2019-10-07 |
Amgen Inc |
Mecanismo de insercion para dispositivo de suministro de farmacos.
|
|
CA3050927A1
(en)
|
2017-03-06 |
2018-09-13 |
Brian Stonecipher |
Drug delivery device with activation prevention feature
|
|
WO2018164829A1
(en)
|
2017-03-07 |
2018-09-13 |
Amgen Inc. |
Needle insertion by overpressure
|
|
MX2019010671A
(es)
|
2017-03-09 |
2019-10-21 |
Amgen Inc |
Mecanismo de insercion para dispositivo de administracion de farmacos.
|
|
AU2018235928B2
(en)
|
2017-03-14 |
2023-09-21 |
Amgen Inc. |
Control of total afucosylated glycoforms of antibodies produced in cell culture
|
|
SG11201907676PA
(en)
|
2017-03-28 |
2019-09-27 |
Amgen Inc |
Plunger rod and syringe assembly system and method
|
|
MX2019014615A
(es)
|
2017-06-08 |
2020-02-07 |
Amgen Inc |
Dispositivo de administracion de farmacos accionado por par de torsion.
|
|
EP3634539A1
(en)
|
2017-06-08 |
2020-04-15 |
Amgen Inc. |
Syringe assembly for a drug delivery device and method of assembly
|
|
CA3066918A1
(en)
|
2017-06-12 |
2018-12-20 |
Bluefin Biomedicine, Inc. |
Anti-il1rap antibodies and antibody drug conjugates
|
|
MX2019015472A
(es)
|
2017-06-22 |
2020-02-19 |
Amgen Inc |
Reduccion del impacto/choque de la activacion del mecanismo.
|
|
AU2018290302B2
(en)
|
2017-06-23 |
2024-02-29 |
Amgen Inc. |
Electronic drug delivery device comprising a cap activated by a switch assembly
|
|
EP3651832B1
(en)
|
2017-07-14 |
2023-12-13 |
Amgen Inc. |
Needle insertion-retraction system having dual torsion spring system
|
|
US11672733B2
(en)
|
2017-07-21 |
2023-06-13 |
Amgen Inc. |
Gas permeable sealing member for drug container and methods of assembly
|
|
US11617837B2
(en)
|
2017-07-25 |
2023-04-04 |
Amgen Inc. |
Drug delivery device with gear module and related method of assembly
|
|
WO2019022950A1
(en)
|
2017-07-25 |
2019-01-31 |
Amgen Inc. |
DRUG DELIVERY DEVICE WITH CONTAINER ACCESS SYSTEM AND ASSEMBLY METHOD THEREOF
|
|
MA49838A
(fr)
|
2017-08-09 |
2020-06-17 |
Amgen Inc |
Systèm de administration de médicaments avec pression hydraulique-pneumatique de chambre
|
|
US11077246B2
(en)
|
2017-08-18 |
2021-08-03 |
Amgen Inc. |
Wearable injector with sterile adhesive patch
|
|
US11103636B2
(en)
|
2017-08-22 |
2021-08-31 |
Amgen Inc. |
Needle insertion mechanism for drug delivery device
|
|
EP3691717B1
(en)
|
2017-10-04 |
2023-02-08 |
Amgen Inc. |
Flow adapter for drug delivery device
|
|
CN111132711B
(zh)
|
2017-10-06 |
2022-07-01 |
安进公司 |
带有联锁组件的药物递送装置及相关组装方法
|
|
IL273323B2
(en)
|
2017-10-09 |
2024-10-01 |
Amgen Inc |
Drug delivery device with drive assembly and related assembly method
|
|
MA50527A
(fr)
|
2017-11-03 |
2020-09-09 |
Amgen Inc |
Système et approches pour stériliser un dispositif d'administration de médicament
|
|
IL273664B1
(en)
|
2017-11-06 |
2026-02-01 |
Amgen Inc |
Full-fledged assemblies and related methods
|
|
JP2021501616A
(ja)
|
2017-11-06 |
2021-01-21 |
アムジエン・インコーポレーテツド |
配置及び流量検出を備える薬物送達デバイス
|
|
CA3079665A1
(en)
|
2017-11-10 |
2019-05-16 |
Amgen Inc. |
Plungers for drug delivery devices
|
|
MX2020004996A
(es)
|
2017-11-16 |
2020-08-27 |
Amgen Inc |
Un mecanismo de pestillo de puerta para un dispositivo de administracion de farmacos.
|
|
EP3710089A1
(en)
|
2017-11-16 |
2020-09-23 |
Amgen Inc. |
Autoinjector with stall and end point detection
|
|
CN111787981B
(zh)
|
2018-03-01 |
2025-12-30 |
瑞泽恩制药公司 |
增加肌肉量和减少脂肪量的方法
|
|
BR112020019559A2
(pt)
|
2018-03-26 |
2021-01-12 |
Amgen Inc. |
Glicoformas afucosiladas totais de anticorpos produzidos em cultura de células
|
|
DK3773713T3
(da)
|
2018-04-06 |
2025-08-18 |
Regeneron Pharma |
Leptinreceptoragonistantistof til anvendelse i forøgelse af knoglemasse hos et individ, der lider af metabolisk dysfunktion eller hypoleptinæmI
|
|
US10835685B2
(en)
|
2018-05-30 |
2020-11-17 |
Amgen Inc. |
Thermal spring release mechanism for a drug delivery device
|
|
US11083840B2
(en)
|
2018-06-01 |
2021-08-10 |
Amgen Inc. |
Modular fluid path assemblies for drug delivery devices
|
|
US12303677B2
(en)
|
2018-07-24 |
2025-05-20 |
Amgen Inc. |
Hybrid drug delivery devices with optional grip portion and related method of preparation
|
|
MA53379A
(fr)
|
2018-07-24 |
2021-06-02 |
Amgen Inc |
Dispositifs d'administration pour l'administration de médicaments
|
|
WO2020023336A1
(en)
|
2018-07-24 |
2020-01-30 |
Amgen Inc. |
Hybrid drug delivery devices with grip portion
|
|
EP3826699A1
(en)
|
2018-07-24 |
2021-06-02 |
Amgen Inc. |
Delivery devices for administering drugs
|
|
CA3103105A1
(en)
|
2018-07-31 |
2020-02-06 |
Amgen Inc. |
Fluid path assembly for a drug delivery device
|
|
MA53724A
(fr)
|
2018-09-24 |
2021-12-29 |
Amgen Inc |
Systèmes et procédés de dosage interventionnel
|
|
MA53718A
(fr)
|
2018-09-28 |
2022-01-05 |
Amgen Inc |
Ensemble d'activation d'échappement de fil de muscle pour un dispositif d'administration de médicament
|
|
TWI857975B
(zh)
|
2018-10-02 |
2024-10-11 |
美商安進公司 |
具有內部力傳遞的用於藥物遞送之注射系統
|
|
TW202529830A
(zh)
|
2018-10-05 |
2025-08-01 |
美商安進公司 |
具有劑量指示器之藥物遞送裝置
|
|
MA53912A
(fr)
|
2018-10-15 |
2022-01-19 |
Amgen Inc |
Dispositif d'administration de médicament comprenant un mécanisme d'amortissement
|
|
EA202191038A1
(ru)
|
2018-10-15 |
2021-07-06 |
Эмджен Инк. |
Способ платформенной сборки для устройства доставки лекарственного средства
|
|
AU2019370159B2
(en)
|
2018-11-01 |
2025-05-29 |
Amgen Inc. |
Drug delivery devices with partial drug delivery member retraction
|
|
TWI831847B
(zh)
|
2018-11-01 |
2024-02-11 |
美商安進公司 |
部分針頭縮回之藥物遞送裝置及其操作方法
|
|
EP3873566B1
(en)
|
2018-11-01 |
2024-11-27 |
Amgen Inc. |
Drug delivery devices with partial drug delivery member retraction
|
|
KR20210104744A
(ko)
|
2018-12-18 |
2021-08-25 |
리제너론 파마슈티칼스 인코포레이티드 |
렙틴 수용체, gdf8 및 액티빈 a에 대한 길항제를 사용하여 체중 및 제지방 근육량을 향상시키기 위한 조성물 및 방법
|
|
WO2020219482A1
(en)
|
2019-04-24 |
2020-10-29 |
Amgen Inc. |
Syringe sterilization verification assemblies and methods
|
|
AU2020284038A1
(en)
*
|
2019-05-30 |
2021-12-02 |
Acceleron Pharma Inc. |
ActRII-binding proteins and uses thereof
|
|
JP7608439B2
(ja)
|
2019-08-23 |
2025-01-06 |
アムジエン・インコーポレーテツド |
構成可能な針シールド係合構成要素を備えた薬物送達デバイス及び関連方法
|
|
MX2022003461A
(es)
|
2019-09-26 |
2022-04-19 |
Amgen Inc |
Metodos de produccion de composiciones de anticuerpos.
|
|
WO2021142191A1
(en)
|
2020-01-08 |
2021-07-15 |
Regeneron Pharmaceuticals, Inc. |
Treatment of fibrodysplasia ossificans progressiva
|
|
WO2021247892A1
(en)
|
2020-06-04 |
2021-12-09 |
Amgen Inc. |
Assessment of cleaning procedures of a biotherapeutic manufacturing process
|
|
IL300362A
(en)
|
2020-08-20 |
2023-04-01 |
Regeneron Pharma |
Methods to prevent and treat poor cardiac function and covid-19 with activin A antagonists
|
|
AU2021360897A1
(en)
|
2020-10-15 |
2023-05-25 |
Amgen Inc. |
Relative unpaired glycans in antibody production methods
|
|
CA3197104A1
(en)
*
|
2020-11-11 |
2022-05-19 |
Hq Han |
Bifunctional antagonists of activin/tgf-beta and rankl and uses thereof
|
|
US20250270304A1
(en)
*
|
2020-12-23 |
2025-08-28 |
Phenomic Ai |
Anti-activin antibodies and methods of using the same
|
|
KR20240011135A
(ko)
|
2021-05-21 |
2024-01-25 |
암젠 인크 |
약물 용기를 위한 충전 레시피를 최적화하는 방법
|
|
EP4352094A1
(en)
|
2021-06-07 |
2024-04-17 |
Amgen Inc. |
Using fucosidase to control afucosylation level of glycosylated proteins
|
|
AU2022361382A1
(en)
|
2021-10-05 |
2024-03-28 |
Amgen Inc. |
Fc-gamma receptor ii binding and glycan content
|
|
AU2022373330A1
(en)
*
|
2021-10-18 |
2024-05-16 |
Adimab, Llc |
Anti-activin a antibodies, compositions and uses thereof
|
|
WO2023147107A1
(en)
*
|
2022-01-31 |
2023-08-03 |
Byomass Inc. |
Myeloproliferative conditions
|
|
WO2023215725A1
(en)
|
2022-05-02 |
2023-11-09 |
Fred Hutchinson Cancer Center |
Compositions and methods for cellular immunotherapy
|
|
CN120187750A
(zh)
|
2022-09-21 |
2025-06-20 |
瑞泽恩制药公司 |
治疗肥胖、糖尿病和肝功能障碍的方法
|
|
WO2024220916A1
(en)
|
2023-04-20 |
2024-10-24 |
Amgen Inc. |
Methods of determining relative unpaired glycan content
|
|
WO2025038600A1
(en)
|
2023-08-14 |
2025-02-20 |
Amgen Inc. |
Methods for reducing yellow color
|
|
WO2025101820A1
(en)
|
2023-11-08 |
2025-05-15 |
Fred Hutchinson Cancer Center |
Compositions and methods for cellular immunotherapy
|
|
WO2026030152A1
(en)
|
2024-07-29 |
2026-02-05 |
Amgen Inc. |
System and method for assessing transferability of a fill recipe
|
|
WO2026037938A1
(en)
|
2024-08-16 |
2026-02-19 |
Protuoso Pte. Ltd. |
Fusion proteins comprising a glp-1 receptor agonist and a myostatin pathway inhibitor
|